889 related articles for article (PubMed ID: 34481722)
1. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
[TBL] [Abstract][Full Text] [Related]
4. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
5. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
6. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
F1000Res; 2022; 11():30. PubMed ID: 35811795
[No Abstract] [Full Text] [Related]
7. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
[No Abstract] [Full Text] [Related]
8. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
De Francesco MA; Signorini L; Piva S; Pellizzeri S; Fumarola B; Corbellini S; Piccinelli G; Simonetti F; Carta V; Mangeri L; Padovani M; Vecchiati D; Latronico N; Castelli F; Caruso A
J Med Virol; 2023 Jul; 95(7):e28892. PubMed ID: 37394790
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea.
Jeong S; Lee N; Park Y; Kim J; Jeon K; Park MJ; Song W
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216039
[TBL] [Abstract][Full Text] [Related]
10. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
11. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of secondary bacteremia in patients with COVID-19.
Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
J Infect Chemother; 2023 Apr; 29(4):422-426. PubMed ID: 36682606
[TBL] [Abstract][Full Text] [Related]
13. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
14. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
Ripa M; Galli L; Poli A; Oltolini C; Spagnuolo V; Mastrangelo A; Muccini C; Monti G; De Luca G; Landoni G; Dagna L; Clementi M; Rovere Querini P; Ciceri F; Tresoldi M; Lazzarin A; Zangrillo A; Scarpellini P; Castagna A;
Clin Microbiol Infect; 2021 Mar; 27(3):451-457. PubMed ID: 33223114
[TBL] [Abstract][Full Text] [Related]
15. Bacterial coinfections in COVID-19: an underestimated adversary.
Fattorini L; Creti R; Palma C; Pantosti A; ;
Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
18. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
[TBL] [Abstract][Full Text] [Related]
19. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
20. Respiratory co-infections in COVID-19-positive patients.
M Abd El-Halim R; Hafez H; Albahet I; Sherif B
Eur J Med Res; 2023 Sep; 28(1):317. PubMed ID: 37660059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]